Chats Answer
Open Label Extension (OLE) trials involve continued treatment with an investigational drug after the conclusion of the initial clinical trial, allowing all participants to receive the active treatment without a placebo group. Data collection in OLE trials can be managed by both CROs and individual care providers:
1. **CROs**: They often manage OLE trials, particularly for larger-scale studies or those sponsored by pharmaceutical companies. CROs handle the logistical aspects of the trial, including data collection, monitoring, and analysis, ensuring consistency and regulatory compliance.
2. **Individual Care Providers**: In smaller or more localized OLE trials, individual care providers may collect data directly. This approach allows for detailed, real-world data collection and may be more feasible for smaller studies or those conducted in specific clinical settings.
The choice of who gathers the data in an OLE trial depends on factors such as the trial's scale, the sponsor's resources, and the study's design and objectives.
Market Data 
Markets 
